WilmerHale Represents General Catalyst in Connection with $18.5 Billion Deal

WilmerHale Represents General Catalyst in Connection with $18.5 Billion Deal

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
WilmerHale has advised General Catalyst, the largest shareholder of Livongo, in connection with the merger of Livongo and Teladoc Health. The merger, valued at $18.5 billion, brings together complementary leaders in virtual care and chronic condition management to create a global leader in consumer centered virtual care. The transaction is expected to close by the end of the fourth quarter of 2020, subject to customary closing conditions.

The WilmerHale team representing General Catalyst includes Jason Kropp, Hal Leibowitz, Andrew Bonnes and Molly Fox.

Read the full press release.
 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel